Skip to main content
All lobbying filings

DRUG POLICY ALLIANCE

DRUG POLICY ALLIANCE filed a Q1 report for DRUG POLICY ALLIANCE on April 19, 2026.

Lobbying for DRUG POLICY ALLIANCE

All filings by DRUG POLICY ALLIANCE · Everything DRUG POLICY ALLIANCE has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 19, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New York

Official filing document

 Lobbyists on this filing 1
  • HANNA SHARIF-KAZEMI
    Previously held: Policy Manager

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Lobbying activity 3
Law Enforcement/Crime/Criminal Justice

We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).

Civil Rights/Civil Liberties

We urged Congress to support the RESTORE Act (H.R. 5223), a bill that would end the SNAP drug felony ban. We urged Congress to repeal the Thurmond Amendment to end housing discrimination via a bill called the Fair Future Act (H.R. 7765).

Health Issues

We urged Congress to fully fund health programs that support people struggling with addiction in Congressional spending bills. We opposed the inclusion of a rider to ban overdose prevention centers in Congressional spending bills.

 Bills named in this filing 8

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem